Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis

被引:108
作者
Telzak, EE
Fazal, BA
Pollard, CL
Turett, GS
Justman, JE
Blum, S
机构
[1] ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10467
[2] ALBERT EINSTEIN COLL MED,DEPT EPIDEMIOL & SOCIAL MED,BRONX,NY 10467
关键词
D O I
10.1086/513772
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
For hospitalized patients with smear-positive pulmonary or laryngeal tuberculosis, the Centers far Disease Control and Prevention recommends that three consecutive sputum samples be negative for acid-fast bacilli (AFB) before respiratory isolation is discontinued. Limited data are available to predict the length of time to obtain three negative sputum smears and cultures and to determine factors associated with a prolonged interval before sputum smear and culture conversion, especially among patients infected with human immunodeficiency virus (HIV). For 100 consecutive patients with smear-positive pulmonary tuberculosis, the mean and median numbers of days from the initiation of appropriate therapy to the first of three consecutive negative smears were calculated, and associated risk factors were determined. The mean number of days before the first of three consecutive negative sputum smears was 33 days; the median was 23 days. On stepwise multiple regression analysis, cavitary disease, numerous AFB on the initial smear, and no prior history of tuberculosis were the factors independently associated with an increased number of days for both smear and culture conversion. HIV does not prolong the period of infectiousness.
引用
收藏
页码:666 / 670
页数:5
相关论文
共 32 条
[1]  
[Anonymous], 1994, MMWR
[2]   QUANTITATIVE BACILLARY RESPONSE TO TREATMENT IN HIV-ASSOCIATED PULMONARY TUBERCULOSIS [J].
BRINDLE, RJ ;
NUNN, PP ;
GITHUI, W ;
ALLEN, BW ;
GATHUA, S ;
WAIYAKI, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04) :958-961
[3]  
BROOKS SM, 1973, AM REV RESPIR DIS, V108, P799
[4]  
Cauthen GM, 1996, AM J EPIDEMIOL, V144, P69, DOI 10.1093/oxfordjournals.aje.a008856
[5]  
Centers for Disease Control Prevention, 1991, MMWR-MORBID MORTAL W, V40, P585
[6]   AN OUTBREAK OF TUBERCULOSIS WITH ACCELERATED PROGRESSION AMONG PERSONS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS - AN ANALYSIS USING RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS [J].
DALEY, CL ;
SMALL, PM ;
SCHECTER, GF ;
SCHOOLNIK, GK ;
MCADAM, RA ;
JACOBS, WR ;
HOPEWELL, PC .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04) :231-235
[7]  
Dannenberg AM, 1994, TUBERCULOSIS, V3rd, P17
[8]  
DIPERRI G, 1989, LANCET, V2, P1502
[9]   AN OUTBREAK OF MULTIDRUG-RESISTANT TUBERCULOSIS AMONG HOSPITALIZED-PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
EDLIN, BR ;
TOKARS, JI ;
GRIECO, MH ;
CRAWFORD, JT ;
WILLIAMS, J ;
SORDILLO, EM ;
ONG, KR ;
KILBURN, JO ;
DOOLEY, SW ;
CASTRO, KG ;
JARVIS, WR ;
HOLMBERG, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (23) :1514-1521
[10]  
ELLIOTT AM, 1993, AIDS, V7, P981, DOI 10.1097/00002030-199307000-00012